Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

FDA Prediction, page-18

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 18 Last

Share
Profile

Follow
C'mon go up!

358 Posts.

76

08/10/19

10:33

Post #: 40768999
Share

Originally posted by nogur1223: ↑

Obviously FDA will be the crown jewel, which will see the share price increase exponentially following it. However, I am not as confident that we will get it as I was for CE/TGA (harder regulatory process/average US results/inability to use AU trial results in the application). I wouldn't be surprised if they come back to us and tell us we need more trials to be done in the USA. I have held other stocks (AVH) long before they got FDA approval and it was a painful process. Nevertheless, I don't necessarily think that is a bad thing. We have CE/TGA and now we are on the road to commercialisation/deals with prospective partners in Europe and Australia. The news flow that is expected from this, as well as the increasingly successful Sleep Apnoea arm of the business, will ensure that the SP doesn't suffer for too long following a negative FDA approval. Further, the US market is a different beast. With the limited cash we have, entering multiple markets at once could be detrimental to the health of the business. It wouldn’t be a bad thing if we have to just focus on EU/AU market, then expand into the US later on. Regardless of what happens in the FDA decision, I am confident that we are destined for success in the medium to long term. I look forward to the exciting months ahead.

Expand

You raise some very valid points. Good post!

RAP Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
7 Upvote

1 Great analysis

Reply

Top Stories

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

VUL

Vulcan appoints investment bank and M&A veteran to board

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

There are more pages in this discussion • 63 more messages in this thread...

First 18 Last

Add RAP (ASX) to my watchlist

FDA Prediction, page-18

Top Stories

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Utah authorities sign off on Anson's lithium extraction plans at Green River

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Vulcan appoints investment bank and M&A veteran to board

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Featured News